Caprolactam Chemicals , a prominent player in the chemical industry, held its 36th Annual General Meeting (AGM) on September 25, 2025, where shareholders approved several significant appointments and reappointments.

Leadership Continuity

The shareholders gave their nod to the reappointment of Ms. Zaver Shankarlal Bhanushali as the company's Managing Director for another five-year term. Her new tenure will run from August 7, 2025, to August 6, 2030. Ms. Bhanushali brings 22 years of management experience to the role and has been instrumental in handling the company's day-to-day operations and procurement activities.

In a move that ensures continuity in the company's financial leadership, Mr. Siddharth Shankarlal Bhanushali was reappointed as Whole Time Director and Chief Financial Officer (CFO) for a five-year term coinciding with that of Ms. Bhanushali. Mr. Siddharth Bhanushali, a Chemical Engineer who graduated from the University of Sydney in 2002, brings 15 years of chemical industry experience to his role.

New Secretarial Auditor

The shareholders also approved the appointment of M/s. Alpi Nehra and Associates as the company's Secretarial Auditors for a five-year term, commencing from the conclusion of the AGM.

Board Recommendations and Regulatory Compliance

These appointments and reappointments were previously recommended by the company's Board of Directors. Caprolactam Chemicals has confirmed that both Ms. Zaver Bhanushali and Mr. Siddharth Bhanushali are not debarred from holding office by any regulatory authority, ensuring compliance with corporate governance standards.

Family Leadership

The reappointments highlight the continued involvement of the Bhanushali family in the company's top management. Ms. Zaver Shankarlal Bhanushali is the mother of Mr. Siddharth Shankarlal Bhanushali, creating a strong family leadership structure at the helm of Caprolactam Chemicals.

These approvals by the shareholders demonstrate confidence in the current leadership and their vision for the company's future. As Caprolactam Chemicals moves forward with its experienced management team, stakeholders will be watching closely to see how these leaders steer the company through the evolving landscape of the chemical industry.

Caprolactam Chemicals Ltd. has reported a significant turnaround in its financial performance for the first quarter of the fiscal year 2025-26, along with announcing key details for its upcoming 36th Annual General Meeting (AGM).

Financial Performance Highlights

The company's unaudited financial results for the quarter ended June 30, 2025, show a remarkable improvement:

Caprolactam Chemicals has successfully turned its previous quarter's loss into a profit, with a significant increase in revenue from operations. The company's profit after tax stood at ₹36.21 lakhs, compared to a loss of ₹45.07 lakhs in the previous quarter. This positive shift is also reflected in the earnings per share, which improved from a loss of ₹0.98 to a profit of ₹0.79 per share.

36th Annual General Meeting Announcements

The Board of Directors, in their meeting held on August 14, 2025, approved these results and made several key decisions regarding the upcoming 36th AGM:

1. AGM Date and Time: The 36th AGM is scheduled for Thursday, September 25, 2025, at 10:30 A.M.

2. E-Voting Details:

   • Record Date: September 17, 2025
   • E-Voting Period: September 20, 2025 (9:00 A.M.) to September 24, 2025 (5:00 P.M.)

3. Appointments:

   • Mr. Rahul Shivji Gori has been appointed as the scrutinizer for the e-voting process.
   • Purva Sharegistry (India) Pvt. Ltd. has been appointed to provide e-voting services for the AGM.

4. Director's Report: The Board approved the Director's Report along with Annexures for the financial year ended March 31, 2025.

Management Commentary

Mrs. Zaver S Bhanushali, Managing Director of Caprolactam Chemicals Ltd., signed off on the financial results, demonstrating the management's confidence in the company's performance and future prospects.

The company's ability to significantly increase its revenue and turn a profit in a challenging economic environment showcases its operational efficiency and market resilience. Shareholders and investors will likely be keen to hear more about the company's strategies and outlook during the upcoming AGM.

Caprolactam Chemicals Ltd. continues to comply with regulatory requirements, including the timely submission of its financial results and AGM details to the BSE Limited.